Pegylated interferon
Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012:[1]
- Pegylated interferon-alpha-2a
- Pegylated interferon-alpha-2b
- Pegylated interferon-beta-1a[2]
In these formulations, Polyethylene glycol (PEG) is added to make interferon last longer in the body.[3] They are used to treat both hepatitis B,[4] hepatitis C[1] and multiple sclerosis.[2]
Pegylated interferon is contraindicated in patients with hyperbilirubinaemia.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.medscape.com/viewarticle/407963_5 Hepatology Focus: Update on Hepatitis C Treatment: Pegylated Interferon
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
